SCLC, EXTENSIVE STAGE
Clinical trials for SCLC, EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SCLC, EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SCLC, EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy shows promise for aggressive lung cancer
Disease control CompletedThis study tested a combination of two drugs (durvalumab and anlotinib) plus standard chemotherapy as a first treatment for people with extensive-stage small cell lung cancer, a fast-growing cancer. The goal was to see if this triple therapy could delay cancer growth better than …
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 17, 2026 01:51 UTC
-
New hope for advanced lung cancer patients in poor health?
Disease control CompletedThis study tested a combination of the immunotherapy drug atezolizumab plus standard chemotherapy in 70 people with extensive-stage small cell lung cancer who were in poor health (ECOG 2). The goal was to see if this treatment is safe and helps them live longer. While immunothera…
Matched conditions: SCLC, EXTENSIVE STAGE
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated May 06, 2026 16:02 UTC